Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
6.8% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
7
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
2.0% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
1
users have commented on this narrative
17
users have followed this narrative
8 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.9% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
12
users have liked this narrative
4
users have commented on this narrative
12
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
FiscalNote Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Global Policy Intelligence Will Fuel Transition Amid Challenges
Key Takeaways Rising demand for policy intelligence, driven by regulatory complexity and digital transformation, is boosting contract values, customer retention, and recurring revenue potential. Strategic innovations, customer migration to new platforms, and financial restructuring are strengthening operational flexibility and paving the way for sustained growth and profitability.
View narrative
US$2.85
FV
82.2% undervalued
intrinsic discount
-4.84%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
5 days ago
author updated this narrative
NX Filtration
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
New Dutch Factory And OEM Partnerships Will Fuel Market Expansion
Key Takeaways The new factory in the Netherlands and strengthened OEM partnerships are set to significantly boost production, operational efficiency, and future revenue growth. Global sales expansion and innovative technology investments focus on water scarcity solutions, enhancing market penetration and bolstering NX Filtration's ESG reputation.
View narrative
€4.24
FV
18.6% undervalued
intrinsic discount
68.97%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
5 days ago
author updated this narrative
MediWound
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Advanced Wound Care Demand Will Unlock Global Opportunities
Key Takeaways Expanding manufacturing and favorable reimbursement shifts are expected to unlock suppressed product demand, boost sales, and improve gross margins. Diversification through ongoing clinical trials, new product launches, and public sector partnerships should reduce risk and strengthen long-term financial stability.
View narrative
US$30.67
FV
43.4% undervalued
intrinsic discount
34.98%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
5 days ago
author updated this narrative
Inventiva
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Phase III Trials Will Advance Lanifibranor For MASH Treatment
Key Takeaways Strategic focus on lanifibranor development, cutting other activities, and reducing workforce may improve net margins through operational efficiency. Key partnerships in Asia and financial strength ensure market penetration and support sustained investment, boosting future earnings potential.
View narrative
€6.20
FV
38.7% undervalued
intrinsic discount
66.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
5 days ago
author updated this narrative
a.k.a. Brands Holding
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Omnichannel Expansion And TikTok Trends Will Drive Global Impact
Key Takeaways Omnichannel expansion, social commerce growth, and international market entry are strengthening brand awareness and fueling recurring revenue and long-term growth prospects. Data-driven merchandising, supply chain flexibility, and strategic pricing are enhancing operating efficiency, earnings quality, and margin stability.
View narrative
US$20.50
FV
46.4% undervalued
intrinsic discount
4.09%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
FuelCell Energy
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Cost Cuts And ExxonMobil Collaboration Will Shape Our Future
Key Takeaways Strategic partnerships and collaborations in energy and hydrogen sectors are boosting revenue growth and market expansion globally, particularly in Asia and the Americas. Cost-cutting and restructuring efforts aim to enhance profitability and improve financial performance through reduced operating expenses.
View narrative
US$7.38
FV
45.3% undervalued
intrinsic discount
33.74%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
46
users have followed this narrative
5 days ago
author updated this narrative
TerrAscend
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Expanding Adult-Use And Medical Cannabis Markets Will Redefine The Industry
Key Takeaways Expansion into newly legalized states and premium product offerings position the company for sustained revenue growth and improved profitability as markets broaden. Vertical integration, strategic M&A, and digital-first initiatives enhance cost efficiency, operating margins, and reduce risk through focus on high-growth, regulated markets.
View narrative
CA$1.88
FV
36.6% undervalued
intrinsic discount
1.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
5 days ago
author updated this narrative
Hansa Biopharma
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Global Organ Transplantation Demand Will Expand Market Opportunity
Key Takeaways Expansion into new markets, improved reimbursement, and strong transplant demand are driving significant sales and margin growth for IDEFIRIX and other biologics. Advancing pipeline diversification and upcoming clinical readouts reduce single-product dependency, positioning for multi-asset growth and enhanced long-term earnings potential.
View narrative
SEK 75.50
FV
58.0% undervalued
intrinsic discount
89.78%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
5 days ago
author updated this narrative
American Outdoor Brands
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
BUBBA Smart Fish Scale And ClayCopter Will Expand Market Reach
Key Takeaways Innovative products and strategic retail partnerships are set to boost brand awareness, market reach, and revenue growth. The asset-light model and focus on subscription revenue support flexible operations and strong margins, enhancing profitability and growth.
View narrative
US$16.50
FV
42.1% undervalued
intrinsic discount
1.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Value any company in seconds
Popular companies